The Future of Powder Formulation Development
Isothermal Dry Particle Coating (iDPC)
Aston Particle Technologies are pioneers in providing innovative formulation solutions for small molecule and biological APIs through patented isothermal dry particle coating (iDPC) technology.
Our integrated suite of applications connected with domain expertise in formulation development and in-house scale-up can offer support across pre-clinical processes to early phase I/II production
Why Choose Aston Particle Technologies?
APT has a well-seasoned industrial management team with decades of experience in large Pharma and Biotech companies.
What We Do
What We Offer
News and Updates
We are attending Respiratory Drug Delivery Europe 2023!
Here at APT, we offer the future of advanced powder blending and formulation development with our patented isothermal dry particle coater (iDPC). Whether you are
Are you currently developing a high-dose respiratory product (intranasal or inhalation)?
Click below to access the second of our two papers from Drug Delivery to the Lungs (DDL) 2022 titled “Modulating the Fine Particle Fraction, Surface Area and
APT’s Innovation Spotlight Talk at DDL 2022
APT’s Development Director Dr. Jasdip Koner, delivered an innovation spotlight talk at the brilliant DDL 2022 conference. This was such a great experience from start